![Structural Modeling and in Silico Screening of Potential Small-Molecule Allosteric Agonists of a Glucagon-like Peptide 1 Receptor | ACS Omega Structural Modeling and in Silico Screening of Potential Small-Molecule Allosteric Agonists of a Glucagon-like Peptide 1 Receptor | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.8b03052/asset/images/large/ao-2018-030526_0009.jpeg)
Structural Modeling and in Silico Screening of Potential Small-Molecule Allosteric Agonists of a Glucagon-like Peptide 1 Receptor | ACS Omega
![Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes | eLife Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes | eLife](https://iiif.elifesciences.org/lax/72919%2Felife-72919-fig2-v2.tif/full/1500,/0/default.jpg)
Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes | eLife
![PDF) Faster Use and Fewer Failures with Needle-Free Nasal Glucagon Versus Injectable Glucagon in Severe Hypoglycemia Rescue: A Simulation Study PDF) Faster Use and Fewer Failures with Needle-Free Nasal Glucagon Versus Injectable Glucagon in Severe Hypoglycemia Rescue: A Simulation Study](https://i1.rgstatic.net/publication/317257669_Faster_Use_and_Fewer_Failures_with_Needle-Free_Nasal_Glucagon_Versus_Injectable_Glucagon_in_Severe_Hypoglycemia_Rescue_A_Simulation_Study/links/5ac66301aca272abdc5cb43f/largepreview.png)
PDF) Faster Use and Fewer Failures with Needle-Free Nasal Glucagon Versus Injectable Glucagon in Severe Hypoglycemia Rescue: A Simulation Study
![JCI - α Cell dysfunction in islets from nondiabetic, glutamic acid decarboxylase autoantibody–positive individuals JCI - α Cell dysfunction in islets from nondiabetic, glutamic acid decarboxylase autoantibody–positive individuals](https://dm5migu4zj3pb.cloudfront.net/manuscripts/156000/156243/medium/JCI156243.ga.jpg)
JCI - α Cell dysfunction in islets from nondiabetic, glutamic acid decarboxylase autoantibody–positive individuals
![Mini-dose glucagon as a novel approach to prevent exercise-induced hypoglycaemia in type 1 diabetes - Virtual Meeting | EASD Mini-dose glucagon as a novel approach to prevent exercise-induced hypoglycaemia in type 1 diabetes - Virtual Meeting | EASD](https://d2t0unnjxes6lt.cloudfront.net/data/easd/data/talks/806_607206/Slide1.jpg)
Mini-dose glucagon as a novel approach to prevent exercise-induced hypoglycaemia in type 1 diabetes - Virtual Meeting | EASD
![Vitamin-D-Binding Protein Contributes to the Maintenance of α Cell Function and Glucagon Secretion - ScienceDirect Vitamin-D-Binding Protein Contributes to the Maintenance of α Cell Function and Glucagon Secretion - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124720307415-fx1.jpg)
Vitamin-D-Binding Protein Contributes to the Maintenance of α Cell Function and Glucagon Secretion - ScienceDirect
![Emergency kit for low blood sugar recalled because it may fail to treat the condition - pennlive.com Emergency kit for low blood sugar recalled because it may fail to treat the condition - pennlive.com](https://www.pennlive.com/resizer/jg4kcs9GZjSfz5ulO3EzEOpxXsM=/1280x0/smart/cloudfront-us-east-1.images.arcpublishing.com/advancelocal/R4UAEGENF5HMJNQVQIG7HOQEE4.jpg)
Emergency kit for low blood sugar recalled because it may fail to treat the condition - pennlive.com
![789 Important Things to Know About Gvoke HypoPen® (glucagon injection) — Juicebox Podcast and Arden's Day 789 Important Things to Know About Gvoke HypoPen® (glucagon injection) — Juicebox Podcast and Arden's Day](https://images.squarespace-cdn.com/content/v1/52a0933ce4b061dbb499e8aa/1668447993061-T55NX7HN82KJXUVKW6ZW/2022-11-10_Xeris_Podcast_2500x1221.jpg?format=1500w)